Streetbeat News

Stock Prices

BBY

Best Buy has updated its financial outlook for FY25, projecting adjusted EPS to be between $5.75 and $6.20, compared to the estimated $6.13. The company also forecasts revenue to range from $41.3 billion to $42.6 billion, against the estimated $42.37 billion.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 2:40 pm

BTU

LPG

PBF

SDRL

TK

Benzinga Insights highlights value stocks in the energy sector with low P/E ratios, including Dorian LPG, PBF Energy, Peabody Energy, Seadrill, and Teekay. The report details recent earnings and dividend yields, indicating potential undervaluation and investment opportunities.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 2:39 pm

ACMR

Benchmark analyst Mark Miller maintains a Buy rating on ACM Research (NASDAQ:ACMR) and raises the price target from $32 to $35.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 2:36 pm

JPM

Over the past 10 years, JPMorgan Chase (NYSE:JPM) has produced an average annual return of 12.27%, outperforming the market by 1.8% annually. A $100 investment in JPM 10 years ago would now be worth $323.12. The company currently has a market capitalization of $532.93 billion.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 2:30 pm

PVH

Over the past 15 years, PVH (NYSE:PVH) has produced an average annual return of 16.13%, outperforming the market by 1.89% annually. A $100 investment in PVH 15 years ago would now be worth $920.32. PVH's current market capitalization stands at $8.17 billion.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 2:30 pm

IPWR

Ideal Power (NASDAQ:IPWR) reported Q4 earnings, beating estimates with an EPS of $-0.39 against an expected $-0.42. Revenue increased by $44 thousand year-over-year. Despite missing EPS estimates last quarter, the share price increased by 11.0% the following day.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 2:30 pm

BBWI

Bath & Body Works, Inc. (NYSE:BBWI) shares fell after reporting Q4 earnings and a modest outlook for Q1 and FY24. Despite beating Q4 earnings and revenue estimates, the company's forecast for net sales and EPS for the full year and Q1 2024 is below consensus estimates. BBWI also announced a new $500 million share repurchase program.

Portfolio Pulse from Nabaparna Bhattacharya

February 29, 2024 | 2:27 pm

IPWR

Ideal Power (NASDAQ:IPWR) reported Q4 2023 earnings with a smaller loss per share of $(0.39) than the estimated $(0.42), beating expectations by 7.14%. Sales for the quarter were $61.48K, marking a significant increase of 270.20% from $16.61K in the same quarter last year.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 2:24 pm

MULN

Mullen Technologies has progressed its solid-state battery pack from lab testing to on-road vehicle testing in its Class 1 EV Cargo Van, achieving an 86% increase in vehicle range from 110 miles to 205 miles, surpassing the previously projected 73% increase.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 2:23 pm

GSK

GSK Plc (NYSE:GSK) has confidentially settled another lawsuit in California alleging its heartburn drug Zantac caused cancer. This is the second settlement within a month, with previous cases also resolved confidentially. GSK does not admit liability in these settlements. The settlements resolve the final three breast cancer bellwether cases in California, exempting GSK from further pre-trial hearings. Zantac was a top-selling medication but was pulled from the market in 2020 due to carcinogenic concerns. GSK's stock rose 1.02 to $42.77 in premarket trading.

Portfolio Pulse from Vandana Singh

February 29, 2024 | 2:21 pm